
Elizabeth A. Burkhart
Examiner (ID: 12400, Phone: (571)272-6647 , Office: P/1715 )
| Most Active Art Unit | 1715 |
| Art Unit(s) | 1762, 1715, 1792 |
| Total Applications | 919 |
| Issued Applications | 503 |
| Pending Applications | 11 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 382832
[patent_doc_number] => 07306784
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-11
[patent_title] => 'Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy'
[patent_app_type] => utility
[patent_app_number] => 10/374035
[patent_app_country] => US
[patent_app_date] => 2003-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 24508
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/306/07306784.pdf
[firstpage_image] =>[orig_patent_app_number] => 10374035
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/374035 | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy | Feb 24, 2003 | Issued |
Array
(
[id] => 890872
[patent_doc_number] => 07344700
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-18
[patent_title] => 'Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy'
[patent_app_type] => utility
[patent_app_number] => 10/371210
[patent_app_country] => US
[patent_app_date] => 2003-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23929
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/344/07344700.pdf
[firstpage_image] =>[orig_patent_app_number] => 10371210
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/371210 | Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy | Feb 23, 2003 | Issued |
Array
(
[id] => 6678114
[patent_doc_number] => 20030228254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-11
[patent_title] => 'Contrast agents'
[patent_app_type] => new
[patent_app_number] => 10/370092
[patent_app_country] => US
[patent_app_date] => 2003-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20599
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20030228254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10370092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/370092 | Contrast agents | Feb 20, 2003 | Issued |
Array
(
[id] => 6710430
[patent_doc_number] => 20030170179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Near infrared imaging agent'
[patent_app_type] => new
[patent_app_number] => 10/368997
[patent_app_country] => US
[patent_app_date] => 2003-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8006
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170179.pdf
[firstpage_image] =>[orig_patent_app_number] => 10368997
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/368997 | Near infrared imaging agent | Feb 18, 2003 | Issued |
Array
(
[id] => 382831
[patent_doc_number] => 07306783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-11
[patent_title] => 'Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy'
[patent_app_type] => utility
[patent_app_number] => 10/368280
[patent_app_country] => US
[patent_app_date] => 2003-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 10
[patent_no_of_words] => 22422
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/306/07306783.pdf
[firstpage_image] =>[orig_patent_app_number] => 10368280
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/368280 | Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy | Feb 17, 2003 | Issued |
Array
(
[id] => 7175763
[patent_doc_number] => 20050123477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-09
[patent_title] => 'Benzothiazole derivatives for in vivo imaging of amloid plaques'
[patent_app_type] => utility
[patent_app_number] => 10/504231
[patent_app_country] => US
[patent_app_date] => 2003-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5303
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0123/20050123477.pdf
[firstpage_image] =>[orig_patent_app_number] => 10504231
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/504231 | Benzothiazole derivatives for in vivo imaging of amloid plaques | Feb 11, 2003 | Abandoned |
Array
(
[id] => 7607888
[patent_doc_number] => 07097824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-29
[patent_title] => 'Tuftsin metallopeptide analogs and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/364842
[patent_app_country] => US
[patent_app_date] => 2003-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7657
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/097/07097824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10364842
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/364842 | Tuftsin metallopeptide analogs and uses thereof | Feb 10, 2003 | Issued |
Array
(
[id] => 7387074
[patent_doc_number] => 20040029872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Inhibition of psychostimulant-induced and nicotine-induced craving'
[patent_app_type] => new
[patent_app_number] => 10/364303
[patent_app_country] => US
[patent_app_date] => 2003-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17259
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20040029872.pdf
[firstpage_image] =>[orig_patent_app_number] => 10364303
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/364303 | Inhibition of psychostimulant-induced and nicotine-induced craving | Feb 9, 2003 | Abandoned |
Array
(
[id] => 390049
[patent_doc_number] => 07300644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-27
[patent_title] => 'Targeted combination immunotherapy'
[patent_app_type] => utility
[patent_app_number] => 10/361026
[patent_app_country] => US
[patent_app_date] => 2003-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12308
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 295
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/300/07300644.pdf
[firstpage_image] =>[orig_patent_app_number] => 10361026
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/361026 | Targeted combination immunotherapy | Feb 9, 2003 | Issued |
Array
(
[id] => 6821222
[patent_doc_number] => 20030219383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Intramolecularly-quenched near infrared fluorescent probes'
[patent_app_type] => new
[patent_app_number] => 10/360890
[patent_app_country] => US
[patent_app_date] => 2003-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6342
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219383.pdf
[firstpage_image] =>[orig_patent_app_number] => 10360890
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/360890 | Intramolecularly-quenched near infrared fluorescent probes | Feb 6, 2003 | Abandoned |
Array
(
[id] => 650741
[patent_doc_number] => 07112318
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-26
[patent_title] => 'Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts'
[patent_app_type] => utility
[patent_app_number] => 10/360566
[patent_app_country] => US
[patent_app_date] => 2003-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 13656
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/112/07112318.pdf
[firstpage_image] =>[orig_patent_app_number] => 10360566
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/360566 | Non-invasive diagnostic imaging technology for mitochondria dysfunction using radiolabeled lipophilic salts | Feb 5, 2003 | Issued |
Array
(
[id] => 7138144
[patent_doc_number] => 20050182027
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-18
[patent_title] => 'Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts'
[patent_app_type] => utility
[patent_app_number] => 10/503690
[patent_app_country] => US
[patent_app_date] => 2003-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13644
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20050182027.pdf
[firstpage_image] =>[orig_patent_app_number] => 10503690
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/503690 | Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts | Feb 5, 2003 | Issued |
Array
(
[id] => 6702118
[patent_doc_number] => 20030224998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors'
[patent_app_type] => new
[patent_app_number] => 10/248668
[patent_app_country] => US
[patent_app_date] => 2003-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7109
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20030224998.pdf
[firstpage_image] =>[orig_patent_app_number] => 10248668
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/248668 | Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors | Feb 5, 2003 | Issued |
Array
(
[id] => 6729599
[patent_doc_number] => 20030185789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Lipase inhibiting polymers'
[patent_app_type] => new
[patent_app_number] => 10/359458
[patent_app_country] => US
[patent_app_date] => 2003-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11691
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0185/20030185789.pdf
[firstpage_image] =>[orig_patent_app_number] => 10359458
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/359458 | Lipase inhibiting polymers | Feb 4, 2003 | Issued |
Array
(
[id] => 1059753
[patent_doc_number] => 06852843
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-08
[patent_title] => 'Phosphorus supported carbene transition metal complexes'
[patent_app_type] => utility
[patent_app_number] => 10/356884
[patent_app_country] => US
[patent_app_date] => 2003-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7581
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852843.pdf
[firstpage_image] =>[orig_patent_app_number] => 10356884
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/356884 | Phosphorus supported carbene transition metal complexes | Feb 2, 2003 | Issued |
Array
(
[id] => 7362346
[patent_doc_number] => 20040005273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Methods for in vivo evaluation of pulmonary physiology and/or function using NMR signals of polarized Xe'
[patent_app_type] => new
[patent_app_number] => 10/356240
[patent_app_country] => US
[patent_app_date] => 2003-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20759
[patent_no_of_claims] => 124
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10356240
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/356240 | Methods for in vivo evaluation of pulmonary physiology and/or function using NMR signals of polarized Xe | Jan 30, 2003 | Issued |
Array
(
[id] => 7142628
[patent_doc_number] => 20050118101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-02
[patent_title] => 'Beta-homolysine conjugates and their use as transport enhancer'
[patent_app_type] => utility
[patent_app_number] => 10/502533
[patent_app_country] => US
[patent_app_date] => 2003-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7267
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20050118101.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502533 | Beta-homolysine conjugates and their use as transport enhancer | Jan 26, 2003 | Abandoned |
Array
(
[id] => 314515
[patent_doc_number] => 07524483
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-04-28
[patent_title] => 'Responsive paramagnetic MRI contrast agents'
[patent_app_type] => utility
[patent_app_number] => 10/502701
[patent_app_country] => US
[patent_app_date] => 2003-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 17
[patent_no_of_words] => 9963
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/524/07524483.pdf
[firstpage_image] =>[orig_patent_app_number] => 10502701
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/502701 | Responsive paramagnetic MRI contrast agents | Jan 26, 2003 | Issued |
Array
(
[id] => 7270433
[patent_doc_number] => 20040058951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Integrin targeted imaging agents'
[patent_app_type] => new
[patent_app_number] => 10/351463
[patent_app_country] => US
[patent_app_date] => 2003-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17055
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058951.pdf
[firstpage_image] =>[orig_patent_app_number] => 10351463
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/351463 | Integrin targeted imaging agents | Jan 23, 2003 | Issued |
Array
(
[id] => 7363541
[patent_doc_number] => 20040014964
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-22
[patent_title] => 'Vitronectin receptor antagonist pharmaceuticals'
[patent_app_type] => new
[patent_app_number] => 10/348268
[patent_app_country] => US
[patent_app_date] => 2003-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45556
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20040014964.pdf
[firstpage_image] =>[orig_patent_app_number] => 10348268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/348268 | Vitronectin receptor antagonist pharmaceuticals | Jan 20, 2003 | Issued |